Arcus Biosciences, Inc.
RCUSNYSECIK 1724521HealthcareFiscal year ends Dec 31
Reports and events: 146 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2320:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001724521-26-000050 |
| 2026-10-2120:09 ET | 8-K | 2.02 Results of operations | 0001193125-26-427829 |
| 2026-10-2012:33 ET | 8-K | 8.01 Other events | 0001724521-26-000047 |
| 2026-08-0520:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001724521-26-000044 |
| 2026-08-0520:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-26-000042 |
| 2026-06-1220:12 ET | 8-K | 5.07 Shareholder vote results | 0001724521-26-000037 |
| 2026-05-0520:11 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001724521-26-000034 |
| 2026-05-0520:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-26-000032 |
| 2026-04-2120:06 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001724521-26-000025 |
| 2026-04-2011:56 ET | 8-K | 8.01 Other events | 0001724521-26-000021 |
| 2026-03-2311:46 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001724521-26-000014 |
| 2026-02-2521:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001724521-26-000009 |
| 2026-02-2521:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-26-000007 |
| 2025-12-1821:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001724521-25-000122 |
| 2025-12-1213:34 ET | 8-K | 8.01 Other events | 0001724521-25-000120 |
| 2025-11-0321:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-262589 |
| 2025-10-2820:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001724521-25-000116 |
| 2025-10-2820:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-25-000114 |
| 2025-10-1413:00 ET | 8-K | 8.01 Other events | 0001724521-25-000109 |
| 2025-10-0614:02 ET | 8-K | 8.01 Other events | 0001724521-25-000107 |
| 2025-08-0620:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001724521-25-000101 |
| 2025-08-0620:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-25-000099 |
| 2025-06-1220:21 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001724521-25-000078 |
| 2025-06-0212:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001724521-25-000066 |
| 2025-05-0620:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001724521-25-000063 |
| 2025-05-0620:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-25-000061 |
| 2025-04-2220:09 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001724521-25-000052 |
| 2025-02-2521:09 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001724521-25-000040 |
| 2025-02-2521:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-25-000039 |
| 2025-02-1921:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-029591 |
| 2025-02-1811:44 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001193125-25-028110 |
| 2025-02-0622:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001724521-25-000024 |
| 2025-01-2121:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001724521-25-000005 |
| 2024-12-1702:52 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-280681 |
| 2024-11-0621:25 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001724521-24-000160 |
| 2024-11-0621:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-24-000159 |
| 2024-10-2420:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001724521-24-000153 |
| 2024-08-2720:12 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001724521-24-000144 |
| 2024-08-0820:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001724521-24-000138 |
| 2024-08-0820:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-24-000136 |
| 2024-06-0620:28 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001724521-24-000101 |
| 2024-06-0312:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001724521-24-000099 |
| 2024-05-2320:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001724521-24-000096 |
| 2024-05-0820:08 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001724521-24-000092 |
| 2024-05-0820:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-24-000090 |
| 2024-04-2320:08 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001724521-24-000079 |
| 2024-02-2121:16 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001724521-24-000052 |
| 2024-02-2121:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001724521-24-000050 |
| 2024-01-3013:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001724521-24-000034 |
| 2023-11-0721:11 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001724521-23-000021 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.